We can't find the internet
Attempting to reconnect
18146.1 PFLS-LS
18146.1 PFLS-LS
Résumé
Development of novel antibiotics with additional host-protective anti-inflammatory properties against life threatening infections caused by MDR Gram-negative ESKAPE pathogens
Textes supplémentaires
Abstract
In earlier work, POL7080 was discovered; an antibiotic targeting Pseudomonas aeruginosa with a novel mode-of-action, which is currently in Phase II clinical trials. In this project, a new series of peptidomimetics with a broader spectrum of antibacterial activity against multi-drug resistant (MDR) and colistin-resistant Gram-negative ESKAPE pathogens will be studied, possessing also potential host-protective anti-inflammatory activity.
Participants
Daniel Obrecht
Wirtschaftspartner
daniel.obrecht@polyphor.com
Spexis AG CHE-108.535.251 Daniel Obrecht Hegenmattweg 125 4123 Allschwil BL CH
John A. Robinson
Kontaktperson
robinson@oci.uzh.ch
Universität Zürich Organisch-chemisches Institut John A. Robinson Winterthurerstrasse 190 8057 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2015-12-31
- Date de fin
- 2018-12-31
- Coûts totaux approuvés
- CHF 993600.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%